No First Use of Nuclear Weapons, & More from CRS
Recent reports from the Congressional Research Service that have not been publicly released include the following.
U.S. Nuclear Weapons Policy: Considering “No First Use”, CRS Insight, August 16, 2016
Coordinated Party Expenditures in Federal Elections: An Overview, updated August 15, 2016
Introduction to FEMA’s National Flood Insurance Program (NFIP), August 16, 2016
The United Arab Emirates (UAE): Issues for U.S. Policy, updated August 16, 2016
Airline Passenger Rights: The Federal Role in Aviation Consumer Protection, August 17, 2016
Legal Status of CEQ’s Final Guidance on Climate Change in Environmental Reviews under NEPA, CRS Legal Sidebar, August 17, 2016
U.S. Trade Deficit and the Impact of Changing Oil Prices, updated August 16, 2016
General Policy Statements: Legal Overview, April 14, 2016
Dude, Where’s My Jurisdiction? Congressional Efforts to Strip Federal Courts of Jurisdiction, CRS Legal Sidebar, August 17, 2016
As surrogate markers are increasingly being accepted by FDA to support approval of new drugs and biologics, it is imperative that patients and clinicians understand whether such novel endpoints are reflective of meaningful clinical benefits.
The Secretary of Health and Human Services should launch a Department-wide initiative to reduce wasteful spending on health services, drugs, and ineffective medical devices, saving many lives as well as billions of dollars annually.
Now that the One Big Beautiful Bill is law, the elimination of clean energy tax credits will cause a nation of higher energy bills – even for consumers and states that aren’t using clean energy.
Bureaucracy significantly hinders federally funded scientific research, diverting scientists’ time from discovery to low-value administrative tasks.